Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: Developmental consequences of germline Ras/MAPK activation on myogenesis

William E. Tidyman, Han S. Lee, Katherine A Rauen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Cardio-facio-cutaneous syndrome (CFC) and Costello syndrome (CS) are two of the more rare RASopathies caused by altered signal transduction of the Ras/mitogen-activated protein kinase (MAPK) pathway. All of the RASopathies exhibit some degree of hypotonia, but CS and CFC are more severe. To determine if individuals with CS and CFC have an underlying skeletal myopathy, we systematically evaluated skeletal muscle pathology in both conditions. We reviewed pathology reports from six individuals who had undergone a skeletal muscle biopsy, and we reviewed histology slides on two cases with CS and one case with CFC. All patients in the cohort had histopathologic findings, and two consistent abnormalities were identified. The first was the presence of abnormal muscle fiber size and variability, and the second was the presence of type 2 fiber predominance. Given the degree of hypotonia typically present in these patients, the overall architecture of the muscle was relatively normal, without showing indications of severe structural histopathology or metabolic abnormalities. Because the Ras/MAPK pathway is vital for skeletal myogenesis, we evaluated the effects of CS and CFC mutations on myogenesis using C2C12 myoblasts. All CS/CFC mutations inhibited myoblast differentiation as indicated by fewer myosin heavy chain expressing cells and a decrease in the number of myotubes as compared to controls. These findings indicate that CS and CFC may have a true myopathy related to an inherent dysregulation of skeletal myogenesis, which further expands our understanding of the consequences of germline Ras/MAPK mutations.

Original languageEnglish (US)
Pages (from-to)104-114
Number of pages11
JournalAmerican Journal of Medical Genetics, Part C: Seminars in Medical Genetics
Volume157
Issue number2
DOIs
StatePublished - May 15 2011
Externally publishedYes

Fingerprint

Costello Syndrome
Muscle Development
Mitogen-Activated Protein Kinases
Skeletal Muscle
Pathology
Muscle Hypotonia
Myoblasts
Muscular Diseases
Mutation
Muscles
Myosin Heavy Chains
Skeletal Muscle Fibers
Cardiofaciocutaneous syndrome
Signal Transduction
Histology
Biopsy

Keywords

  • BRAF
  • Cardio-facio-cutaneous syndrome
  • Costello syndrome
  • HRAS
  • MEK1
  • MEK2
  • Myopathy
  • Ras/MAPK
  • RASopathy
  • Signal transduction pathway
  • Skeletal myogenesis
  • Type 2 predominance

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

@article{25c62f6ddbeb4a56af4265615d12046b,
title = "Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: Developmental consequences of germline Ras/MAPK activation on myogenesis",
abstract = "Cardio-facio-cutaneous syndrome (CFC) and Costello syndrome (CS) are two of the more rare RASopathies caused by altered signal transduction of the Ras/mitogen-activated protein kinase (MAPK) pathway. All of the RASopathies exhibit some degree of hypotonia, but CS and CFC are more severe. To determine if individuals with CS and CFC have an underlying skeletal myopathy, we systematically evaluated skeletal muscle pathology in both conditions. We reviewed pathology reports from six individuals who had undergone a skeletal muscle biopsy, and we reviewed histology slides on two cases with CS and one case with CFC. All patients in the cohort had histopathologic findings, and two consistent abnormalities were identified. The first was the presence of abnormal muscle fiber size and variability, and the second was the presence of type 2 fiber predominance. Given the degree of hypotonia typically present in these patients, the overall architecture of the muscle was relatively normal, without showing indications of severe structural histopathology or metabolic abnormalities. Because the Ras/MAPK pathway is vital for skeletal myogenesis, we evaluated the effects of CS and CFC mutations on myogenesis using C2C12 myoblasts. All CS/CFC mutations inhibited myoblast differentiation as indicated by fewer myosin heavy chain expressing cells and a decrease in the number of myotubes as compared to controls. These findings indicate that CS and CFC may have a true myopathy related to an inherent dysregulation of skeletal myogenesis, which further expands our understanding of the consequences of germline Ras/MAPK mutations.",
keywords = "BRAF, Cardio-facio-cutaneous syndrome, Costello syndrome, HRAS, MEK1, MEK2, Myopathy, Ras/MAPK, RASopathy, Signal transduction pathway, Skeletal myogenesis, Type 2 predominance",
author = "Tidyman, {William E.} and Lee, {Han S.} and Rauen, {Katherine A}",
year = "2011",
month = "5",
day = "15",
doi = "10.1002/ajmg.c.30298",
language = "English (US)",
volume = "157",
pages = "104--114",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes

T2 - Developmental consequences of germline Ras/MAPK activation on myogenesis

AU - Tidyman, William E.

AU - Lee, Han S.

AU - Rauen, Katherine A

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Cardio-facio-cutaneous syndrome (CFC) and Costello syndrome (CS) are two of the more rare RASopathies caused by altered signal transduction of the Ras/mitogen-activated protein kinase (MAPK) pathway. All of the RASopathies exhibit some degree of hypotonia, but CS and CFC are more severe. To determine if individuals with CS and CFC have an underlying skeletal myopathy, we systematically evaluated skeletal muscle pathology in both conditions. We reviewed pathology reports from six individuals who had undergone a skeletal muscle biopsy, and we reviewed histology slides on two cases with CS and one case with CFC. All patients in the cohort had histopathologic findings, and two consistent abnormalities were identified. The first was the presence of abnormal muscle fiber size and variability, and the second was the presence of type 2 fiber predominance. Given the degree of hypotonia typically present in these patients, the overall architecture of the muscle was relatively normal, without showing indications of severe structural histopathology or metabolic abnormalities. Because the Ras/MAPK pathway is vital for skeletal myogenesis, we evaluated the effects of CS and CFC mutations on myogenesis using C2C12 myoblasts. All CS/CFC mutations inhibited myoblast differentiation as indicated by fewer myosin heavy chain expressing cells and a decrease in the number of myotubes as compared to controls. These findings indicate that CS and CFC may have a true myopathy related to an inherent dysregulation of skeletal myogenesis, which further expands our understanding of the consequences of germline Ras/MAPK mutations.

AB - Cardio-facio-cutaneous syndrome (CFC) and Costello syndrome (CS) are two of the more rare RASopathies caused by altered signal transduction of the Ras/mitogen-activated protein kinase (MAPK) pathway. All of the RASopathies exhibit some degree of hypotonia, but CS and CFC are more severe. To determine if individuals with CS and CFC have an underlying skeletal myopathy, we systematically evaluated skeletal muscle pathology in both conditions. We reviewed pathology reports from six individuals who had undergone a skeletal muscle biopsy, and we reviewed histology slides on two cases with CS and one case with CFC. All patients in the cohort had histopathologic findings, and two consistent abnormalities were identified. The first was the presence of abnormal muscle fiber size and variability, and the second was the presence of type 2 fiber predominance. Given the degree of hypotonia typically present in these patients, the overall architecture of the muscle was relatively normal, without showing indications of severe structural histopathology or metabolic abnormalities. Because the Ras/MAPK pathway is vital for skeletal myogenesis, we evaluated the effects of CS and CFC mutations on myogenesis using C2C12 myoblasts. All CS/CFC mutations inhibited myoblast differentiation as indicated by fewer myosin heavy chain expressing cells and a decrease in the number of myotubes as compared to controls. These findings indicate that CS and CFC may have a true myopathy related to an inherent dysregulation of skeletal myogenesis, which further expands our understanding of the consequences of germline Ras/MAPK mutations.

KW - BRAF

KW - Cardio-facio-cutaneous syndrome

KW - Costello syndrome

KW - HRAS

KW - MEK1

KW - MEK2

KW - Myopathy

KW - Ras/MAPK

KW - RASopathy

KW - Signal transduction pathway

KW - Skeletal myogenesis

KW - Type 2 predominance

UR - http://www.scopus.com/inward/record.url?scp=79955029798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955029798&partnerID=8YFLogxK

U2 - 10.1002/ajmg.c.30298

DO - 10.1002/ajmg.c.30298

M3 - Article

C2 - 21495178

AN - SCOPUS:79955029798

VL - 157

SP - 104

EP - 114

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 2

ER -